Dat Xanh Group JSC (HOSE:DXG)

Intercept Pharmaceuticals Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,272,062	1,249,079	276,069	918,979	2,737,677	1,779,631
Short-Term Investments	102,814	-	-	181,166	285,928	205,684
Cash & Short-Term Investments	3,374,876	1,249,079	276,069	1,100,145	3,023,605	1,985,315
Cash Growth	197.44%	352.45%	-74.91%	-63.62%	52.30%	80.64%
Accounts Receivable	1,443,723	1,498,206	1,267,564	1,521,565	1,534,494	1,228,680
Other Receivables	6,345,136	68,341	132,025	-21,210	1,095,632	760,078
Receivables	8,376,572	1,803,181	2,146,810	2,416,044	3,246,359	2,475,432
Inventory	14,133,394	13,406,215	14,139,059	14,030,956	11,238,341	10,251,681
Prepaid Expenses	120,192	125,530	130,027	131,203	112,009	109,132
Other Current Assets	3,551,579	9,549,340	9,537,793	9,692,583	7,634,727	4,901,481
Total Current Assets	29,556,613	26,133,344	26,229,757	27,370,931	25,255,041	19,723,042
Property, Plant & Equipment	1,043,219	1,033,999	1,032,815	1,039,805	1,020,611	970,536
Long-Term Investments	469,990	442,902	394,226	506,494	353,361	106,500
Goodwill	105,052	118,216	144,543	170,871	209,766	236,837
Other Intangible Assets	67,758	71,014	61,909	65,475	68,675	29,894
Long-Term Deferred Tax Assets	97,689	103,036	179,822	253,303	207,236	190,282
Other Long-Term Assets	1,342,979	1,264,239	729,438	913,788	1,139,370	2,054,342
Total Assets	32,683,301	29,183,374	28,786,441	30,320,666	28,254,061	23,311,433
Accounts Payable	755,206	728,691	767,205	1,149,359	848,970	604,014
Accrued Expenses	1,416,648	796,438	782,100	761,080	1,768,317	689,078
Short-Term Debt	1,954,974	809,865	1,099,624	987,466	968,347	572,619
Current Portion of Long-Term Debt	-	2,420,503	1,491,132	1,035,418	1,994,459	1,496,329
Current Income Taxes Payable	-	328,713	12,840	582,986	859,557	451,474
Current Unearned Revenue	82,176	3,047,750	4,149,866	5,014,624	4,073,192	4,281,984
Other Current Liabilities	5,474,256	2,334,349	3,314,808	2,724,066	2,743,880	2,223,022
Total Current Liabilities	9,683,260	10,466,308	11,617,575	12,254,999	13,256,722	10,318,521
Long-Term Debt	3,939,335	3,325,422	2,698,544	3,748,480	1,517,105	3,876,368
Long-Term Deferred Tax Liabilities	148,636	186,530	155,751	98,234	93,264	4,572
Other Long-Term Liabilities	2,972	2,832	128,204	134,022	5,495	27,931
Total Liabilities	13,774,204	13,981,093	14,600,073	16,235,735	14,872,586	14,227,392
Common Stock	10,206,317	7,224,509	6,117,790	6,117,790	5,977,730	5,200,347
Additional Paid-In Capital	302,358	283,153	80,398	80,398	10,678	10,678
Retained Earnings	538,662	1,601,700	1,847,215	2,414,984	2,751,544	923,829
Treasury Stock	-2,501	-2,501	-2,501	-2,501	-2,501	-2,501
Comprehensive Income & Other	1,360,256	1,360,256	1,360,256	634,480	32,030	21,830
Total Common Equity	12,405,093	10,467,118	9,403,159	9,245,152	8,769,482	6,154,183
Minority Interest	6,504,005	4,735,163	4,783,209	4,839,780	4,611,993	2,929,858
Shareholders' Equity	18,909,097	15,202,281	14,186,368	14,084,932	13,381,475	9,084,041
Total Liabilities & Equity	32,683,301	29,183,374	28,786,441	30,320,666	28,254,061	23,311,433
Total Debt	5,894,309	6,555,789	5,289,300	5,771,365	4,479,911	5,945,316
Net Cash (Debt)	-2,519,434	-5,306,710	-5,013,231	-4,671,220	-1,456,306	-3,960,001
Net Cash Per Share	-2782.66	-6437.28	-6996.37	-6588.57	-2055.89	-5678.64
Filing Date Shares Outstanding	889.46	843.22	713.74	713.74	697.35	697.36
Total Common Shares Outstanding	889.46	843.22	713.74	713.74	697.35	697.36
Working Capital	19,873,353	15,667,035	14,612,182	15,115,931	11,998,319	9,404,521
Book Value Per Share	13946.82	12413.23	13174.55	12953.17	12575.44	8825.03
Tangible Book Value	12,232,282	10,277,888	9,196,707	9,008,807	8,491,041	5,887,452
Tangible Book Value Per Share	13752.53	12188.81	12885.29	12622.03	12176.16	8442.54
Buildings	-	289,570	290,654	292,480	414,054	257,470
Machinery	-	159,503	160,082	180,213	180,687	146,885
Construction In Progress	743,086	735,268	722,515	711,409	662,694	645,337

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.